ReviewFoods (Basel, Switzerland)2025
Polyphenol-Rich Beverages Exert Beneficial but Variable Effects on Oxidative, and Inflammatory Markers in Metabolic Syndrome and Related Conditions: Evidence of Human Trials.
Review in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic syndrome (MetS), one of the major global health concerns, represents a cluster of cardiometabolic risk factors along with chronic low-grade inflammation and oxidative stress as essential features. Lifestyle changes, including the health quality of the foods, are recommended as the initial interventions for the management and eventual reversal of metabolic syndrome. Considering the heterogeneity of the studies in evaluating the health benefits of polyphenol-rich foods, there is a lack of quantitative and even qualitative analysis of their potential impact on this pathophysiological condition. This review aimed to provide a coherent, clinically oriented appraisal of the potential role of polyphenol-rich juices and beverages in the management of metabolic syndrome and related cardio-metabolic conditions. Twenty-three human intervention studies, encompassing randomized controlled, crossover, and parallel-group designs, as well as non-randomized or uncontrolled intervention studies that prospectively evaluated a defined beverage. The collective evidence indicates polyphenols could improve anthropometric parameters and blood lipid levels, while data on insulin and blood pressure seemed inconsistent and limited. Regarding the antioxidant effects, most beverages beneficially affected lipid peroxidation and total antioxidant activity. Findings across the studies portray polyphenol-rich juices and beverages as consistent, though not uniformly potent, modulators of low-grade inflammation in cardiometabolic contexts. To draw any firm conclusions, future trials are recommended. These should adopt consistent polyphenol quantification and dosage applied, standardize analyzed parameters including inflammatory and oxidative stress panels, stratify participants by baseline status and medication use, and extend follow-up to evaluate reliability and clinical significance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.